Hepion Pharmaceuticals Inc (HEPA) stock is lower by -70.49% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives HEPA stock a score of 28 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 4. HEPA's rank also includes a short-term technical score of 6.
HEPA has an Overall Score of 28. Find out what this means to you and get the rest of the rankings on HEPA!
Hepion Pharmaceuticals Inc (HEPA) stock has fallen -1.51% while the S&P 500 is lower by -0.13% as of 11:23 AM on Thursday, Dec 1. HEPA is lower by -$0.01 from the previous closing price of $0.37 on volume of 212,664 shares. Over the past year the S&P 500 is lower by -9.71% while HEPA is lower by -70.49%. HEPA lost -$0.59 per share in the over the last 12 months.
Click Here to get the full Stock Report for Hepion Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
